Artigo · Revista · 2025

Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy

Mohamed S. Nafie, Mavis Ali, Moayad Abdullah Alwehaibi, Abdulmajeed Abdullah Alayyaf, Muhanna K. Al-Muhanna, Naif Almuqati e mais 5

RSC Advances

• Acesso aberto · Dourado
• 10% mais citados do mundo
• Internacional · 5 países

Lê-lo10.1039/d4ra05966b